The Effectiveness of Ruxolitinib for Acute/Chronic Graft-versus-Host Disease in Children: A Retrospective Study
Wenli Yang,1,* Guanghua Zhu,2,* Maoquan Qin,2 Zhigang Li,3 Bin Wang,2 Jun Yang,2 Tianyou Wang2 1Department of Clinical Nutrition, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, People’s Republic of China; 2Depart...
Saved in:
Main Authors: | Yang W (Author), Zhu G (Author), Qin M (Author), Li Z (Author), Wang B (Author), Yang J (Author), Wang T (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ruxolitinib as front-line therapy in graft versus host disease: Efficacy and safety in children
by: Revathi Raj, et al.
Published: (2021) -
Management of pediatric steroid-refractory graft versus host disease: Challenges and outcome with ruxolitinib and etanercept
by: Sanjana Sarangarajan, et al.
Published: (2024) -
Ruxolitinib for Treatment of Steroid-Refractory Graft-versus-Host Disease: Real-World Data from Chinese Patients
by: Wei C, et al.
Published: (2021) -
Successful Treatment of Refractory Graft-Versus-Host Disease with Ruxolitinib in a Child after Autologous Stem Cell Transplantation
by: Nurşah Eker, et al.
Published: (2022) -
A rare presentation of acute on chronic graft versus host disease
by: Surbhi Khurana, et al.
Published: (2022)